High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β

Spurrell, 2014, Adaptive immunity in cancer immunology and therapeutics, Ecancermedicalscience, 8 Etzioni, 2003, Immune deficiency and autoimmunity, Autoimmun Rev, 2, 364, 10.1016/S1568-9972(03)00052-1 Vinay, 2015, vol. 35, S185 Bhatia, 2014, Cellular and molecular mechanisms in cancer immune escape: a comprehensive review, Expert Rev Clin Immunol, 10, 41, 10.1586/1744666X.2014.865519 Kandalaft, 2011, 30, 141 Własiuk, 2016, PD1/PD1L pathway, HLA-G and T regulatory cells as new markers of immunosuppression in cancers, Postepy Hig Med Dosw (Online), 70, 1044, 10.5604/17322693.1220994 Curiel, 2004, Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nat Medicine, 10, 942, 10.1038/nm1093 Sato, 2005, Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer, Proc Natl Acad Sci U S A, 102, 18538, 10.1073/pnas.0509182102 Wolf, 2005, The expression of the regulatory T cell–specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer, Clin Cancer Res, 11, 8326, 10.1158/1078-0432.CCR-05-1244 Okazaki, 2007, PD-1 and PD-1 ligands: from discovery to clinical application, Int Immunol, 19, 813, 10.1093/intimm/dxm057 Leach, 1996, Enhancement of antitumor immunity by CTLA-4 blockade, Science, 271, 1734, 10.1126/science.271.5256.1734 S-m, 2011, Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies, Histol Histopathol, 26, 409 Rouas-Freiss, 1997, Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis, Proc Natl Acad Sci U S A, 94, 11520, 10.1073/pnas.94.21.11520 Selmani, 2009, HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells, Transplantation, 87, S62, 10.1097/TP.0b013e3181a2a4b3 Carosella, 2011, The tolerogenic interplay (s) among HLA-G, myeloid APCs, and regulatory cells, Blood, 118, 6499, 10.1182/blood-2011-07-370742 Naji, 2014, Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses, J Immunol, 192, 1536, 10.4049/jimmunol.1300438 Carosella, 2008, Beyond the increasing complexity of the immunomodulatory HLA-G molecule, Blood, 111, 4862, 10.1182/blood-2007-12-127662 2018 Lin, 2012, HLA-G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer, Int J Cancer, 131, 150, 10.1002/ijc.26375 Jung, 2009, Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer, Reprod Sci, 16, 1103, 10.1177/1933719109342131 Sheu, 2007, vol. 17, 436 Rafii, 2008, Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours, PLoS One, 3, 10.1371/journal.pone.0003894 Castells, 2012, Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages, Cancer Lett, 326, 59, 10.1016/j.canlet.2012.07.020 Martinet, 2010, Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses, Int J Cancer, 126, 2143 Pasquet, 2010, Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis, Int J Cancer, 126, 2090 Lis, 2012, Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties, PLoS One, 7, 10.1371/journal.pone.0038340 Berthaut, 2011, Insulin growth factor promotes human corneal fibroblast network formation in vitro, Invest Ophthalmol Vis Sci, 52, 7647, 10.1167/iovs.10-5625 Ahmed, 2013, Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research, Front Oncol, 3, 256, 10.3389/fonc.2013.00256 Guan, 2015, TGF-β induces HLA-G expression through inhibiting miR-152 in gastric cancer cells, J Biomed Sci, 22, 107, 10.1186/s12929-015-0177-4 Jemal, 2008, Cancer statistics, 2008, CA Cancer J Clin, 58, 71, 10.3322/CA.2007.0010 Bhoola, 2006, Diagnosis and management of epithelial ovarian cancer, Obstet Gynecol, 107, 1399, 10.1097/01.AOG.0000220516.34053.48 Eisenkop, 2006, “Optimal” cytoreduction for advanced epithelial ovarian cancer: a commentary, Gynecol Oncol, 103, 329, 10.1016/j.ygyno.2006.07.004 Selle, 2014, A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma, Ann Oncol, 25, 2191, 10.1093/annonc/mdu392 Pfisterer, 2006, vol. 33, 12 Konopleva, 2002, Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins, Leukemia, 16, 1713, 10.1038/sj.leu.2402608 Martinet, 2010, PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling, Biochem Pharmacol, 80, 838, 10.1016/j.bcp.2010.05.002 Nasef, 2006, Identification of IL-10 and TGF-β transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells, Gene Expr, 13, 217, 10.3727/000000006780666957 Rebmann, 2003, Detection of HLA-G5 secreting cells, Hum Immunol, 64, 1017, 10.1016/j.humimm.2003.08.354 Moreau, 1999, IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes, Int Immunol, 11, 803, 10.1093/intimm/11.5.803 Yang, 1995, Cytokine regulation of HLA-G expression in human trophoblast cell lines, J Reprod Immunol, 29, 179, 10.1016/0165-0378(95)00942-E Moreau, 2001, vol. 33, 2277 Lin, 2010, Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma, J Cell Mol Med, 14, 2162, 10.1111/j.1582-4934.2009.00917.x Gupta, 2013, β-defensin-3 negatively regulates TLR4–HMGB1 axis mediated HLA-G expression in IL-1β treated glioma cells, Cell Signal, 25, 682, 10.1016/j.cellsig.2012.12.001 Zhu, 2012, Gene expression profiles of HLA-G1 overexpressed in hES cells, Biochem Genet, 50, 809, 10.1007/s10528-012-9522-4 Castelli, 2014, Transcriptional and posttranscriptional regulations of the HLA-G gene, J Immunol Res, 2014